Threads Lab team members Alison Krentel, Charles Thickstun, and Daniel Dilliott undertook an acceptability study in preparation for the 2019 mass drug administration with the triple drug regimen for the elimination of lymphatic filariasis (LF) in Guyana. Results showed that regional variation occurred across many indicators of interest: self-rated understanding about LF, mechanisms of LF transmission, LF drug safety and history of treatment during MDA. Region IV (Georgetown) recorded higher knowledge about LF, but lower compliance and acceptability. Number of pills was not perceived as a concern.
top of page
bottom of page